Table 3. Univariate and multivatiate analysis of factors for DFS in triple-negative breast cancer patients.

Variable	Category	Univariate analysis			Multivariate analysis
		HR	95% CI	P-value	HR	95% CI	P-value
Age (years)	≥50/<50	1.03	0.310–3.422	0.962	0	0–2.813E + 98	0.945
Menopause	Positive/Negative	0.674	0.203–2.240	0.519	0	0–1.056E + 98	0.939
LVI	Positive/Negative	1.389	0.418–4.618	0.592	0.555	0.116–2.657	0.462
Histological grade	High/Low	1.392	0.419–4.628	0.589	1.371	0.319–5.891	0.671
Tumor size	>5 cm/≤5 cm	1.119	0.245–5.123	0.885	0.263	0.029–2.432	0.24
Node status	Positive/Negative	2.465	0.782–7.773	0.124	2.241	0.241–20.791	0.478
Ki67 status	>20%/≤20%	0.56	0.168–1.869	0.346	0.259	0.050–1.341	0.107
Chemotherapy	Others/Doxorubicin based	1.9	0.572–6.310	0.295	1.011	0.201–5.085	0.989
Radiotherapy	Yes/No	1.666	0.501–5.539	0.405	3.536	0.560–22.318	0.179
p-eIF2α	High/Low	0.28	0.084–0.930	0.038	0.199	0.041–0.973	0.046